Financials
- Market Capitalization 440.89 M
- Employee 22
- Founded 2017
- CEO N/A
- Website www.q32bio.com
- Headquarter Delaware, United States
- FIGI BBG00CTTJWQ9
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
4.08
Relación precio/flujo de caja
120.41
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2786 | CBIO Crescent Biopharma, Inc. - Common Stock | 16.63 USD | -6.31% | -2.98% | +12.21% | +14.77% | 617.70 M USD | ||
| 2842 | EIKN Eikon Therapeutics, Inc. - Common Stock | 10.52 USD | -4.19% | -10.24% | +12.15% | -38.30% | 569.82 M USD | ||
| 3158 | UPB Upstream Bio, Inc. - Common Stock | 6.54 USD | -2.24% | -2.82% | +3.65% | -60.74% | 358.20 M USD | ||
| 3344 | AMRN Amarin Corporation plc - American Depositary Shares, each repre | 13.87 USD | -0.72% | -0.93% | -2.87% | -10.86% | 292.97 M USD |